With the right tools, medical guidance, and lifestyle support, midlife can be a powerful reset for long-term vitality
Mann DL, McMurray JJV, Packer M et al (2004) Targeted anticytokine therapy in patients with chronic heart failure: results of the randomized etanercept worldwide evaluation (RENEWAL)
Whether these safety signals translate equivalently to MC4R -deficient patients - who are predominantly children and adolescents with a distinct metabolic phenotype - remains unknown
These trial-based findings coexist with large-scale observational evidence, such as a target trial emulation including over 270,000 matched patients, which demonstrated a consistent reduction in VTE risk with GLP-1RAs compared to DPP-4i (HR 0.78
It has shown positive preliminary results in several studies of glutathiones ability to affect levels of reactive oxygen species, which may have implications in the reduction of cancer rates
doi: 10.1177/0148607190014005448 44